This map shows the geographic impact of D Marx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Marx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Marx more than expected).
This network shows the impact of papers produced by D Marx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Marx. The network helps show where D Marx may publish in the future.
Co-authorship network of co-authors of D Marx
This figure shows the co-authorship network connecting the top 25 collaborators of D Marx.
A scholar is included among the top collaborators of D Marx based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with D Marx. D Marx is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Asherson, Ronald A., et al.. (2008). Recurrent deep vein thrombosis, ovarian carcinoma and antibodies to mitochondria M5 in a patient with asymptomatic primary "plus" antiphospholipid syndrome: an unusual combination.. PubMed. 25(6). 890–5.4 indexed citations
3.
Meden, H., et al.. (2000). Expression of the mismatch repair protein hMSH2 in carcinoma in situ and invasive cancer of the breast.. PubMed. 20(1A). 119–24.20 indexed citations
4.
Marx, D, et al.. (2000). True. British Journal of Cancer. 82(10). 1662–1670.23 indexed citations
5.
Schneider, J., et al.. (1999). Immunohistochemical detection of HSP60-expression in human ovarian cancer. Correlation with survival in a series of 247 patients.. PubMed. 19(3A). 2141–6.41 indexed citations
6.
Schneider, J., et al.. (1998). Co-expression of the MDR1 gene and HSP27 in human ovarian cancer.. PubMed. 18(4C). 2967–71.34 indexed citations
7.
Meden, H., D Marx, A. Schauer, W. Wuttke, & Walter Kühn. (1997). Prognostic significance of p105 (c-erbB-2 HER2/neu) serum levels in patients with ovarian cancer.. PubMed. 17(1B). 757–60.25 indexed citations
Korabiowska, M, et al.. (1996). Antigen Ki-67 and c-myc oncogene as related to histoclinical parameters in pigmented skin lesions.. PubMed. 9(5). 433–8.10 indexed citations
10.
Korabiowska, M, et al.. (1996). Differential expression of cerbB3 in naevi and malignant melanomas.. PubMed. 16(1). 471–4.7 indexed citations
Korabiowska, M, et al.. (1995). Significance of P-53 antigen in malignant melanomas and naevi of the head and neck area.. PubMed. 15(3). 885–9.21 indexed citations
13.
Marx, D, et al.. (1995). Immunohistochemical localization of CD44 variants 5 and 6 in human gastric mucosa and gastric cancer.. PubMed. 15(4). 1459–65.14 indexed citations
Meden, H., et al.. (1992). [Breast carcinoma in pregnancy. Clinical, histological and immunohistochemical findings].. PubMed. 117(4). 216–9.5 indexed citations
18.
Sauer, Rolf, A. Schauer, M. Schumacher, et al.. (1992). Breast preservation versus mastectomy in early breast cancer--1991 update of the GBSG 1--protocol and prognostic factors. The German Breast Cancer Study Group.. PubMed. 168(4). 191–202.12 indexed citations
Marx, D, et al.. (1973). [Apexo-carotid diagram].. PubMed. 66(10). 1311–23.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.